Results 171 to 180 of about 960,390 (294)

Efficacy and safety of high doses of eltrombopag for treating adult immune thrombocytopenia: Results from a multicentre retrospective cohort study

British Journal of Haematology, EarlyView.
Salomé Dahan, Stéphanie Guillet, Olivier Fain, Delphine Gobert, Stéphane Cheze, Florent Broca, Bertrand Godeau, Marc Michel   +7 more
wiley   +1 more source

Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments

European Journal of Haematology, EarlyView.
ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder caused by a defect of glycosylphosphatidyl‐anchored proteins, leading to an uncontrolled complement‐mediated hemolysis. The advent of complement inhibitors in clinical practice radically changed patients' outcomes and survival.
Bruno Fattizzo, Monia Marchetti, Elisa Cannizzo, Arianna Gatti, Massimo Geuna, Anna Paola Iori, Maddalena Raia, Simona Sica, Francesco Buccisano   +8 more
wiley   +1 more source

Enhancing Diagnostic Precision in Malignant Hematological Disorders Through Risk Factor Analysis for High-Quality Bone Marrow Aspirate. [PDF]

Int J Lab Hematol
Cantu-Rodriguez OG, Dorsey-Trevino EG, Contreras-Arce A, Hawing-Zarate JA, Gonzalez-Cantu SP, Gonzalez-Cantu SL, Gutierrez-Aguirre CH, Colunga-Pedraza P, Gomez-De Leon A, Gomez-Almaguer D.   +9 more
europepmc   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

European Journal of Haematology, EarlyView.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis

European Journal of Haematology, EarlyView.
ABSTRACT Objectives Primary plasma cell leukemia (pPCL) is a rare disease with poor outcomes. As data on randomized phase‐III trials are lacking, treatment recommendations are predominately based on retrospective analyses incorporating time periods with outdated therapies. Thus, the optimal consolidation strategy remains to be defined.
Maria Dampmann, Sarah Flossdorf, Julius Keyl, Theo Leitner, Cyrus Khandanpour, Markus Maulhardt, Evgenii Shumilov, Matthias Stelljes, Lisa Leypoldt, Marie Harzer, Christoph Schaefers, Francis Ayuketang Ayuk, Bastian von Tresckow, Amelie Boquoi, Thomas Schroeder, Hans Christian Reinhardt, Christine Hanoun   +16 more
wiley   +1 more source

Multiple Myeloma Diagnosed by CT-Guided Rib Biopsy after a Hemodilute Bone Marrow Aspirate, in a Patient with a Biclonal Pattern on Serum Protein Electrophoresis. [PDF]

Mediterr J Hematol Infect Dis
Cyrbja A, Seraj L, Qerama S.
europepmc   +1 more source

Platelet concentrates in sinus augmentation: The impact of platelet dose and biological characteristics—A systematic review and meta‐analysis

European Journal of Oral Sciences, EarlyView.
Abstract This systematic review investigated the osteogenic effects of platelet concentrate (PRF/PRP) when combined with non‐autogenous graft materials in sinus lift procedures. Key characteristics assessed included platelet concentration, total platelet dose, leukocyte content, and fibrin‐network structure.
Olav Kansgar Straum, Hans Thomas Brox, Juliane Hesse, Andreas Jörn Schmalfuss, Erlend Bugge   +4 more
wiley   +1 more source

Effect and comparison of bone marrow aspirate concentrate on cartilage regeneration and clinical outcomes following high tibial osteotomy and microfracture. [PDF]

J Orthop Surg Res
Cetin O, Durdi A, Beyzadeoglu T.
europepmc   +1 more source

Short‐term welfare assessment of a single ultrasound‐guided adipose tissue aspiration in standing sedated horses

Equine Veterinary Education, EarlyView.
Summary Background Adipose tissue‐derived mesenchymal stem cells (AT‐MSCs) are entering the market of orthobiologics suitable for managing musculoskeletal disorders in horses, due to their accessibility and reparative capacity. Ethical considerations in developing allogeneic products require a low‐morbidity approach to tissue harvest.
A. Nedergaard, K. M. Kalka, C. Lindegaard   +2 more
wiley   +1 more source

Lateral and posterolateral iliac crest approach for bone marrow aspirate harvest in regenerative orthopedic applications. [PDF]

J Orthop Surg Res
Lana JF, Pires L, Macedo A, Mosaner T, de Moraes Ferreira Jorge D, Costa FR, Tambeli CH, de Andrade MAP.   +7 more
europepmc   +1 more source